Gotham Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.57M | Buy |
119,446
+71,977
| +152% | +$3.96M | 0.04% | 588 |
|
|
2025
Q1 | $3.36M | Buy |
47,469
+35,735
| +305% | +$2.53M | 0.03% | 642 |
|
|
2024
Q4 | $771K | Sell |
11,734
-11,661
| -50% | -$766K | 0.01% | 994 |
|
|
2024
Q3 | $1.64M | Buy |
+23,395
| New | +$1.64M | 0.02% | 783 |
|
|
2024
Q1 | – | Sell |
-2,446
| Closed | -$236K | – | 1380 |
|
|
2023
Q4 | $236K | Sell |
2,446
-1,610
| -40% | -$155K | ﹤0.01% | 1197 |
|
|
2023
Q3 | $359K | Buy |
+4,056
| New | +$359K | 0.01% | 1061 |
|
|
2023
Q2 | – | Sell |
-3,758
| Closed | -$365K | – | 1311 |
|
|
2023
Q1 | $365K | Buy |
+3,758
| New | +$365K | 0.01% | 1067 |
|
|
2021
Q4 | – | Sell |
-3,241
| Closed | -$250K | – | 1144 |
|
|
2021
Q3 | $250K | Buy |
+3,241
| New | +$250K | 0.01% | 898 |
|
|
2020
Q3 | – | Sell |
-5,842
| Closed | -$721K | – | 1035 |
|
|
2020
Q2 | $721K | Sell |
5,842
-5,178
| -47% | -$639K | 0.02% | 652 |
|
|
2020
Q1 | $931K | Buy |
11,020
+2,860
| +35% | +$242K | 0.03% | 565 |
|
|
2019
Q4 | $690K | Buy |
+8,160
| New | +$690K | 0.01% | 711 |
|
|
2017
Q4 | – | Sell |
-3,590
| Closed | -$334K | – | 936 |
|
|
2017
Q3 | $334K | Buy |
+3,590
| New | +$334K | ﹤0.01% | 779 |
|
|
2016
Q3 | – | Sell |
-3,144
| Closed | -$245K | – | 929 |
|
|
2016
Q2 | $245K | Buy |
+3,144
| New | +$245K | ﹤0.01% | 847 |
|
|
2015
Q2 | – | Sell |
-4,195
| Closed | -$523K | – | 926 |
|
|
2015
Q1 | $523K | Buy |
+4,195
| New | +$523K | ﹤0.01% | 683 |
|
|
2014
Q4 | – | Sell |
-3,885
| Closed | -$280K | – | 952 |
|
|
2014
Q3 | $280K | Buy |
+3,885
| New | +$280K | ﹤0.01% | 863 |
|